XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Aug. 02, 2025
Aug. 03, 2024
Cash flows from operating activities:    
Net loss $ (32,003) $ (23,334)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 4,150 5,137
Amortization of debt issuance and original issue discount costs 843 256
Asset impairment 72 31
Gain (loss) on disposal of property and equipment 19 (7)
Stock-based compensation expense 321 556
Changes in assets and liabilities:    
Inventories, net 206 (18,670)
Prepaid expenses and other current assets (727) (613)
Accounts payable 12,403 14,514
Accrued expenses and other liabilities 1,261 (2,207)
Operating lease assets and liabilities (1,411) (1,990)
Other assets and liabilities 4,800 (61)
Net cash used in operating activities (10,066) (26,388)
Cash flows from investing activities:    
Proceeds from sale of property and equipment 18 17
Capital expenditures (1,026) (1,193)
Net cash used in investing activities (1,008) (1,176)
Cash flows from financing activities:    
Borrowings on revolving line of credit 88,644 22,800
Repayments on revolving line of credit (90,124) (4,100)
Borrowings on term loans 5,000 10,000
Payments of debt and equity issuance costs (570) (429)
Cash used in net share settlement of stock options and restricted stock units (55) (51)
Proceeds from issuance of common stock 8,000 0
Net cash provided by financing activities 10,895 28,220
Cash and cash equivalents:    
Net (decrease) increase (179) 656
Beginning of the period 3,820 3,805
End of the period 3,641 4,461
Supplemental schedule of non-cash activities:    
Non-cash accruals for purchases of property and equipment 289 227
Non-cash accruals for debt and equity issuance costs 632 830
Common stock issued in exchange for payment of equity issuance costs 574 0
Conversion of Beyond Credit Agreement into Common Stock [Member]    
Supplemental schedule of non-cash activities:    
Issuance of common stock to Bed Bath & Beyond, Inc. to convert term loan and accrued interest $ 6,676 $ 0